Stock listing

Eisai Co., Ltd.

Selected listing: 4523 · TSE · JPY · JP

Eisai Co., Ltd. (Tokyo:4523), Commercial Services. Latest release Oct 2, 2026: Notification Regarding Receipt of Dividend from a Consolidated Subsidiary.

4523:TSEJPYJPUpdated September 26, 2026

Ticker: Tokyo:4523
Asset type: Stock
Sector: Commercial Services
Industry: Miscellaneous Commercial Services
Exchange: Tokyo
Currency: JPY

About Eisai Co., Ltd.

Eisai Co., Ltd. is a publicly traded company in Japan, listed under the ticker 4523. Eisai focuses on innovative pharmaceutical solutions and is committed to addressing unmet medical needs.

Latest news from Eisai Co., Ltd.

Notification Regarding Receipt of Dividend from a Consolidated Subsidiary

October 2, 2026

U.S. FDA Approves WELIREG® (belzutifan) Plus LENVIMA® (lenvatinib) for Certain Previously Treated Adult Patients With Advanced Renal Cell Carcinoma With a Clear Cell Component (ccRCC)

September 25, 2026

Leqembi® Pen subcutaneous formulation approved in Japan

September 16, 2026

LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Approved in Japan for the Treatment of Early Alzheimer’s Disease

September 16, 2026

Eisai and Osaka Prefecture Enter into Collaboration to Promote Awareness of Dementia and Mild Cognitive Impairment (MCI)

September 15, 2026

All Eisai Co., Ltd. news →

Events

Replays

Eisai Co Ltd (ESALF) Q1 2027 Earnings Call
Mon, Aug 03, 2026 · 03:00 AM ET
Watch
Eisai Co Ltd (ESALF) Q4 2026 Earnings Call
Fri, May 15, 2026 · 03:00 AM ET
Watch
Eisai Co Ltd (ESALF) Q2 2026 Earnings Call
Fri, Nov 07, 2025 · 02:30 AM ET
Watch

Research Eisai Co., Ltd.

Eisai Co., Ltd. company profile

View the public company page for Eisai Co., Ltd. on 6ix.

Eisai Co., Ltd. news

Read company news and market updates connected to Eisai Co., Ltd..

Eisai Co., Ltd. investor events

Find investor webinars, events, and replay context for Eisai Co., Ltd..